ITOCHU Technology Ventures
VC Fund
Tokyo, Japan
ITOCHU Technology Ventures is a VC fund in Tokyo focused on Software and E-Commerce. ITOCHU Technology Ventures (ITV), based in Tokyo, is the venture capital arm of ITOCHU Corporation. ITOCHU is one of the world's largest corporations with offices in over 80 countries and operations that cover a broad spectrum of industries. ITV's mission is to invest and help build leading information technology companies by leveraging avast array of resources both domestically and internationally throughout ITOCHU and its group companies. The ITOCHU group has a long history of funding information technology companies with successes including Siebel Systems, NVIDIA, Openwave and Aruba Networks. Current portfolio includes, Box, Fab, Ooyala, WHILL, Tokyo Otaku Mode, etc.
- Total investments:
- 148
- Last investment:
- Lead investor:
- 22%
- Fund size:
- $1.5B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries ITOCHU Technology Ventures invests in
Stages ITOCHU Technology Ventures invests in
Countries ITOCHU Technology Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Series A
- $4M–$101M
- Series B
- $4.2M–$213M
Investment Focus
Industry
- Software 19 (13%)
- E-Commerce 16 (11%)
- Information Technology 16 (11%)
- Internet 11 (7%)
- Health Care 10 (7%)
Stage
- Series A 33 (22%)
- Series B 30 (20%)
- Funding Round 25 (17%)
- Seed 17 (11%)
- Series D 12 (8%)
Country
- Japan 83 (56%)
- United States 27 (18%)
- Belgium 1 (1%)
- Romania 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shinzo Nakano
Founder, President & CEO
|
Founder, President & CEO | Total investments: 10 | Find email | |
|
Koji Abe
Senior Vice President, Partner
|
Senior Vice President, Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Pixie Dust Technologies is a developer of computational technologies, including its ultrasonic phased array system with which one can generate force in mid-air; transport things in mid-air without touching anything; target and deliver different sounds from person to person in a crowd; direct guide-dogs; and even apply this in agricultural farming. | $20.7M / Series D / May 19, 2026 | |
|
|
Pixie Dust Technologies is a developer of computational technologies, including its ultrasonic phased array system with which one can generate force in mid-air; transport things in mid-air without touching anything; target and deliver different sounds from person to person in a crowd; direct guide-dogs; and even apply this in agricultural farming. | $20.7M / Series D / May 19, 2026 | |
|
|
Electrifying all for the sustainable future | Series C / Apr 08, 2026 | |
|
|
Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services. | $2.4M / Venture - Series Unknown / Apr 01, 2026 | |
|
|
Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services. | $2.4M / Venture - Series Unknown / Apr 01, 2026 | |
|
|
Miresso is a startup firm that offers nuclear fusion power generation services through natural resources. | $28.8M / Series A / Aug 07, 2025 | |
|
|
Pale Blue provides a variety of water propulsion systems with high-performance, affordable price, short-lead time, and reliability. | $10.2M / Series C / Aug 07, 2025 | |
|
|
Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas. | $18.8M / Jul 30, 2025 | |
|
|
Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas. | $18.8M / Jul 30, 2025 | |
|
|
The alumni association management software developed by Alumnote allows schools to manage their alumni associations online. The focus of the company is to undertake loyalty building and marketing for potential donors such as graduates and provides digital tools, and supports the execution of donation acquisition. | $5.2M / Series A / Jul 22, 2025 | |
| See all 148 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does ITOCHU Technology Ventures invest in?
ITOCHU Technology Ventures invests primarily in Software, E-Commerce and Information Technology startups, most often at Series A and Series B stage. Most of the 148 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is ITOCHU Technology Ventures's check size?
ITOCHU Technology Ventures typically joins rounds of $4M–$101M at Series A and $4.2M–$213M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ITOCHU Technology Ventures participates in.
How do I contact ITOCHU Technology Ventures?
Public channels for ITOCHU Technology Ventures include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ITOCHU Technology Ventures?
The team at ITOCHU Technology Ventures includes Shinzo Nakano (Founder, President & CEO) and Koji Abe (Senior Vice President, Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!